Characterization of a clinical Clostridioides difficile isolate with markedly reduced fidaxomicin susceptibility and a V1143D mutation in rpoB
Schwanbeck, Julian, Riedel, Thomas, Laukien, Friederike, Schober, Isabel, Oehmig, Ines, Zimmermann, Ortrud, Overmann, Jörg, Groß, Uwe, Zautner, Andreas E, Bohne, WolfgangVolume:
74
Language:
english
Journal:
Journal of Antimicrobial Chemotherapy
DOI:
10.1093/jac/dky375
Date:
January, 2019
File:
PDF, 285 KB
english, 2019